Sun Pharma Advanced Research Company Share Price Targets
|
Sun Pharma Advanced Research Company Limited |
|||
|
Price: ₹229.03 (2.36%) | ||
| 52 Week Low: ₹108.00 52 Week High: ₹248.75 |
|||
| Market Capital: 4,674.73 Crore (Small-cap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Sun Pharma Advanced Research Company Stock Comparison: Sun Pharma Advanced Research Company vs Orchid Pharma | Sun Pharma Advanced Research Company vs Procter & Gamble Health | Sun Pharma Advanced Research Company vs Strides Pharma Science | Sun Pharma Advanced Research Company vs Vijaya Diagnostic Centre | Sun Pharma Advanced Research Company vs HealthCare Global Enterprises Limited | Sun Pharma Advanced Research Company vs FDC |
|||
Show Table of Contents
Table of Contents
- 1: Sun Pharma Advanced Research Company Recent Performance
- 2: Sun Pharma Advanced Research Company Share Price Target - Tomorrow
- 2.1: Summary
- 3: Sun Pharma Advanced Research Company Share Price Target - Next Week
- 3.1: Weekly Target Summary
- 4: Sun Pharma Advanced Research Company Share Price Target - Next Month
- 4.1: Monthly Target Summary
Sun Pharma Advanced Research Company Recent Performance
Over the past 764 trading days, the value of Sun Pharma Advanced Research Company's stock has gained ₹44.08 (+23.83%). On 24 May 2023, one share was worth ₹184.95 and by 15 Jun 2026, the value jumped to ₹229.03. During this period it created a highest high of ₹472.80 and lowest low of ₹108.00.
Sun Pharma Advanced Research Company Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 255.3 (+11.47%) | Volatility: ATR T2 |
| Tomorrow Target 2 | 244.79 (+6.88%) | Volatility: ATR T1 |
| Tomorrow Target 1 | 240.37 (+4.95%) | Volatility: BB Upper |
| Current Price | 229.03 | Sun Pharma Advanced Research Company's share price as of 15 Jun 2026 |
| Stop Loss 1 | 222.92 (-2.67%) | 23.60% Fib Retrace |
| Stop Loss 2 | 213.97 (-6.58%) | Trend: EMA9 |
| Stop Loss 3 | 213.27 (-6.89%) | Volatility: ATR S1 |
Summary
15 Jun 2026: Sun Pharma Advanced Research Company finished the day at ₹229.03, gaining ₹5.27 (+2.36%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -6.88% to 11.47% with:
- Target prices: ₹240.37 to ₹255.3
- Support levels: ₹222.92 to ₹213.27
- Recent high: ₹233.90
- Recent low: ₹220.26
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sun Pharma Advanced Research Company Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 255.3 (+11.47%) | Volatility: ATR T2 |
| Next Week Target 2 | 244.79 (+6.88%) | Volatility: ATR T1 |
| Next Week Target 1 | 240.37 (+4.95%) | Volatility: BB Upper |
| Current Price | 229.03 | Sun Pharma Advanced Research Company's share price as of 15 Jun 2026 |
| Stop Loss 1 | 215.53 (-5.9%) | 23.60% Fib Retrace |
| Stop Loss 2 | 213.97 (-6.58%) | Trend: EMA9 |
| Stop Loss 3 | 213.27 (-6.89%) | Volatility: ATR S1 |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -6.88% to 11.47% with:
- Upper targets: ₹240.37 to ₹255.3
- Support levels: ₹215.53 to ₹213.27
Sun Pharma Advanced Research Company Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 274.15 (+19.7%) | Volatility: ATR T2 |
| Next Month Target 2 | 256.1 (+11.81%) | Volatility: ATR T1 |
| Next Month Target 1 | 240.37 (+4.95%) | Volatility: BB Upper |
| Current Price | 229.03 | Sun Pharma Advanced Research Company's share price as of 15 Jun 2026 |
| Stop Loss 1 | 213.97 (-6.58%) | Trend: EMA9 |
| Stop Loss 2 | 201.96 (-11.82%) | Volatility: ATR S1 |
| Stop Loss 3 | 194.98 (-14.87%) | 38.20% Weekly Fib Retrace |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -14.87% to 19.70% with:
- Target range: ₹240.37 to ₹274.15
- Support levels: ₹213.97 to ₹194.98
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
